This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction Untangling the Roles of Antidepressants and Mood Stabilizers in the Treatment of Alzheimer’s Disease

Eric M. Reiman

Published: June 17, 2009

Article Abstract

Two articles and a commentary in this issue underscore the need to clarify the roles of antidepressants and mood stabilizers in the treatment of Alzheimer’s disease (AD). Siddique and colleagues investigate the effects of the selective serotonin reuptake inhibitor (SSRI) citalopram on the treatment of irritability and apathy in AD. Hampel and colleagues use a biomarker strategy to investigate the potential of lithium to modify tau phosphorylation, a cardinal feature of AD pathology.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: